AN AGRESULTS INITIATIVE
IMPLEMENTED BY GALVMED
The Brucellosis Vaccine Prize, a US $30 million prize competition, invites vaccine developers ("Solvers") to submit their proposals for - and ultimately develop - a suitable vaccine that is efficacious, safe and viable for use against Brucella melitensis in small ruminants across the developing world.